| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United Kingdom | 14 | |
| #2 | United States | 10 | |
| #3 | EPO (European Patent Office) | 7 | |
| #4 | Australia | 3 | |
| #5 | Hungary | 3 | |
| #6 | Japan | 3 | |
| #7 | WIPO (World Intellectual Property Organization) | 3 | |
| #8 | Canada | 2 | |
| #9 | China | 2 | |
| #10 | Hong Kong | 1 | |
| #11 | Republic of Korea | 1 | |
| #12 | Singapore | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Medical technology | |
| #4 | Environmental technology | |
| #5 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Object sterilising | |
| #5 | Climate change adaptation technologies | |
| #6 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Pettersson Knut | 14 |
| #2 | Frostegård Johan | 13 |
| #3 | Frostegard Johan | 9 |
| #4 | Frostegård Anna | 8 |
| #5 | Thiagarajan Divya | 8 |
| #6 | Reich Jan Christoph | 7 |
| #7 | Camber Ola | 7 |
| #8 | Moks Toomas | 6 |
| #9 | Jan Christoph Reich | 4 |
| #10 | Toomas Moks | 4 |
| Publication | Filing date | Title |
|---|---|---|
| GB202012889D0 | Methods and uses for annexin as | |
| GB202010639D0 | Therapeutic compositions | |
| GB201909868D0 | Therapeutic compositions | |
| GB201813783D0 | Therapeutic compositions | |
| GB201713811D0 | Therapeutic compositions | |
| GB201708477D0 | Therapeutic compositions | |
| GB201706281D0 | Therapeutic compositions | |
| GB201702144D0 | Therapeutic compositions | |
| GB201609903D0 | Therapeutic compositions | |
| WO2016059146A1 | Therapeutic composition comprising annexin v | |
| GB201700973D0 | Purification of Annexin A5 by anion exchange and affinity chromatography | |
| GB201700978D0 | Purification of Annexin A5 from a composition that includes a calcium ion chelator | |
| GB201516516D0 | Process of manufacture | |
| GB201418500D0 | Therapeutic compositions | |
| GB201418299D0 | Therapeutic compositions | |
| HUE030922T2 | Therapeutic and prophylactic methods, uses and compositions comprising anexin a5 |